Abstract The coronavirus disease-2019 (COVID-19) outbreak all over the world has led the
researchers to strive to develop drugs or vaccines to prevent or halt the progression of this …

Abstract Severe Acute Respiratory Syndrome–Coronavirus-2 is responsible for the current
pandemic that has led to more than 10 million confirmed cases of Coronavirus Disease-19 …

Favipiravir (FVP), a pyrazine analog, has shown antiviral activity against a wide variety of
viruses. It is considered to be worth further investigation as a potential candidate drug for …

Purpose This review was aimed to synthesise the best available evidence on the
effectiveness and safety of remdesivir in the treatment of moderate to severe COVID-19 …

The aim of our review is to demonstrate the potential of herbal preparations, specifically
adaptogens for prevention and treatment of respiratory infections, as well as convalescence …

Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different
viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of …

Introduction At this time, there is no specific therapeutic or vaccine for treatment of the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, available drugs for …

Background The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …

In the current work, a simple, economical, accurate, and precise HPLC method with UV
detection was developed to quantify Favipiravir (FVIR) in spiked human plasma using …

Abstract The Coronavirus Disease 2019 (COVID-19) pandemic was declared in early 2020
after several unexplained pneumonia cases were first reported in Wuhan, China, and …